摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(5-methoxy-1H-benzo[d]imidazol-2-ylthio)-N-(4-nitrophenyl)acetamide | 356776-32-4

中文名称
——
中文别名
——
英文名称
2-(5-methoxy-1H-benzo[d]imidazol-2-ylthio)-N-(4-nitrophenyl)acetamide
英文别名
2-[(6-methoxy-1H-benzimidazol-2-yl)sulfanyl]-N-(4-nitrophenyl)acetamide
2-(5-methoxy-1H-benzo[d]imidazol-2-ylthio)-N-(4-nitrophenyl)acetamide化学式
CAS
356776-32-4
化学式
C16H14N4O4S
mdl
MFCD02321063
分子量
358.378
InChiKey
LYQDSNOFTIZWAX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 溶解度:
    二甲基亚砜:≥30mg/mL

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    25
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    138
  • 氢给体数:
    2
  • 氢受体数:
    6

制备方法与用途

生物活性

AG-09/1 是一种特异性甲酰基肽受体 1 (FPR1) 激动剂。FPR 在宿主防御中起着重要作用。

靶点
  • FPR1
体外研究

N-形式基肽通过 G 蛋白偶联受体(FPR)激活吞噬细胞。FPR1 是首个被克隆的 FPR,编码 fMLF 的高亲和力受体。

反应信息

  • 作为产物:
    描述:
    4-甲氧基邻苯二胺盐酸potassium carbonate 、 potassium hydroxide 作用下, 以 乙醇丙酮 为溶剂, 反应 4.0h, 生成 2-(5-methoxy-1H-benzo[d]imidazol-2-ylthio)-N-(4-nitrophenyl)acetamide
    参考文献:
    名称:
    Synthesis and evaluation of novel benzimidazole derivatives as antimicrobial agents
    摘要:
    Benzimidazole analogs bearing electron-withdrawing as well as electron-donating substituent were synthesized to achieve bioactive molecules with significant antimicrobial property. The desired compounds were prepared by multi-step synthesis process. The formation of intermediates and their corresponding derivatives (III (1-13) ) was confirmed by spectral characterization such as H-1 NMR, C-13 NMR, mass spectra, IR, and elemental analysis. The compounds were screened for their antimicrobial properties against a broad panel of Gram-positive and Gram-negative bacteria as well as fungi. From the SAR study data, it was observed that the derivatives with electron-withdrawing functional groups were more bioactive than that with electron-donating functional groups.
    DOI:
    10.1007/s00044-013-0732-z
点击查看最新优质反应信息